Comparison of ADVAIR medication vs Salmeterol vs Albuterol in Asthma patients, assessing lung function and other measures of asthma control. - Trial 2015-004865-10
Access comprehensive clinical trial information for 2015-004865-10 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKiline Research and Development LTD. and is currently status unknown. The study focuses on Asthma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
GlaxoSmithKiline Research and Development LTD.
GlaxoSmithKline
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
The primary measure of efficacy was area under the curve describing AM PEF relative to baseline [AUC(bl)] over the 16 week double-blind treatment period. The primary comparison of interest was between the Arg/Arg and Gly/Gly genotypes in the FSC treatment group.
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2015-004865-10
Non-Device Trial